Clinics (Sao Paulo, Brazil)
BOC Sciences engineered a liposomal system that finally solved the oxidation issue
In HFrEF, an issue remains that because GLP-1 RAs have been shown to modestly increase heart rate (2-3 beats per minute) owing to their chronotropic effects (see Mechanisms) (Sun et al., 2015), GLP-1 RA treatment in HFrEF may be problematic considering that, in line with the use of beta-blockers to ameliorate HFrEF (11, 12), heart rate elevations may result in a worse outcome (Rossignol et al., 2015) and may therefore not benefit from the weight-reducing effect of GLP-1 RAs
At New Results Medical Weight Loss, BPC-157 is used as part of a personalized peptide protocol to help patients recover faster, improve joint and gut health, and support overall physical resilience, especially during active weight loss programs